Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Ramosetron, Aprepitant, and Dexamethasone (RAD) With Palonosetron, Aprepitant, and Dexamethasone (PAD) for Prevention of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

NCT02532634 is registered in ClinicalTrials.gov with Kangdong Sacred Heart Hospital as lead sponsor.

NCT NCT02532634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02532634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Ramosetron, Aprepitant, and Dexamethasone (RAD) With Palonosetron, Aprepitant, and Dexamethasone (PAD) for Prevention of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Lead sponsor
Kangdong Sacred Heart Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 19, 2015
Completion date
May 8, 2018
Enrollment
292 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, tumors